#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2976	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2442	362.4	0	.	n	.	0	A662G	SNP	662	662	A	1120	1120	G	395	G,A,T	344,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2976	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2442	362.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1908	1908	T	471	T	424	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2976	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2442	362.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1642	1642	C	423	C	370	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4816	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3820	377.9	0	.	n	.	0	G262A	SNP	262	262	G	729	729	A	484	A,G	420,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4816	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3820	377.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1804	1804	A	400	A,G	357,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4816	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3820	377.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2438	2438	C	407	C	358	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4816	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3820	377.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2512	2512	A	442	A	370	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4816	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3820	377.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3064	3064	C	477	C	404	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	416	folP	852	852	99.77	folP.l15.c4.ctg.1	1754	71.0	0	.	p	.	0	S68P	NONSYN	202	204	TCG	648	650	CCG	96;96;97	C;C;G	84;83;82	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	416	folP	852	852	99.77	folP.l15.c4.ctg.1	1754	71.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1056	1058	GTA	100;100;100	G;T;A	89;89;88	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	416	folP	852	852	99.77	folP.l15.c4.ctg.1	1754	71.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1128	1130	AGC	108;109;109	A;G;C	92;93;92	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	866	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3743	69.4	1	SNP	p	S91F	0	.	.	271	273	TCC	746	748	TCC	84;83;82	T;C;C	73;72;72	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	866	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3743	69.4	1	SNP	p	D95N	0	.	.	283	285	GAC	758	760	GAC	78;78;79	G;A;C	71;71;72	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	866	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3743	69.4	1	SNP	p	D95G	0	.	.	283	285	GAC	758	760	GAC	78;78;79	G;A;C	71;71;72	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	27	388	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1663	69.9	1	SNP	p	G45D	0	.	.	133	135	GGC	631	633	GGC	127;127;126	G;G;C	111;109;109	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	294	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1246	70.9	0	.	n	.	0	.206T	INS	206	206	T	707	707	T	115	T	101	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	838	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3261	77.1	0	.	p	.	0	G459S	NONSYN	1375	1377	GGT	1806	1808	AGT	97;97;97	A;G;T	85;84;84	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	838	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3261	77.1	1	SNP	p	D86N	0	.	.	256	258	GAC	687	689	GAC	117;116;117	G;A,T;C	92;89,1;95	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	838	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3261	77.1	1	SNP	p	S87I	0	.	.	259	261	AGT	690	692	AGT	116;116;117	A;G;T	92;91;92	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	838	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3261	77.1	1	SNP	p	S87R	0	.	.	259	261	AGT	690	692	AGT	116;116;117	A;G;T	92;91;92	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	838	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3261	77.1	1	SNP	p	S87W	0	.	.	259	261	AGT	690	692	AGT	116;116;117	A;G;T	92;91;92	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	838	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3261	77.1	1	SNP	p	S88P	0	.	.	262	264	TCC	693	695	TCC	118;118;118	T;C;C,T	94;93;92,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	794	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2961	80.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1683	1685	GGC	111;111;111	G;G;C	97;95;96	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1375	1377	GCA	103;103;104	G,T;C,A;A	91,1;91,1;91	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1378	1380	ATC	104;103;103	A;T;C,A	91;91;90,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1390	1392	GTG	102;101;101	G;T;G	90;91;89	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1390	1392	GTG	102;101;101	G;T;G	90;91;89	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1894	1896	ACC	94;94;94	A;C;C	79;78;78	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1948	1950	GCG	94;94;95	G;C,G;G	77;70,1;75	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1948	1950	GCG	94;94;95	G;C,G;G	77;70,1;75	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2071	2073	GGT	83;83;83	G;G;T	76;76;73	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2080	2082	GGC	83;83;82	G;G;C	73;75;74	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	742	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2601	85.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2098	2100	CCG	85;85;83	C;C;G	71;75;74	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1018	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3367	90.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1778	1780	CTG	95;95;95	C;T;G	77;76;77	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	452	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2116	64.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	574	576	GGC	90;90;89	G;G;C	75;74;77	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	452	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2116	64.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	756	756	C	70	C	64	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	T18M	NONSYN	52	54	ACG	435	437	ATG	127;127;127	A;T;G,T	108;111;109,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	T26A	NONSYN	76	78	ACC	459	461	GCC	134;135;137	G;C;C	111;113;115	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	K41D	NONSYN	121	123	AAA	504	506	GAC	152;152;153	G;A;C	124;121;120	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	G140R	NONSYN	418	420	GGA	801	803	AGA	131;131;129	A;G;A	116;116;115	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	810	812	CAA	129;130;131	C,T;A;A	111,1;115;113	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1008	1010	ATG	110;110;110	A;T;G	97;96;98	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	546	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1739	93.5	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	1017	1017	T	107	T	91	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	1826	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5174	105.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2190	2192	CAT	108;107;107	C;A;T	92;93;93	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	278	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1249	66.4	1	SNP	p	V57M	1	.	.	169	171	ATG	630	632	ATG	131;131;131	A;T;G	106;102;106	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
